Recombinant Antibodies Edition 1999 at Meripustak

Recombinant Antibodies Edition 1999

Books from same Author: Frank Breitling, Stefan D?bel

Books from same Publisher: John Wiley

Related Category: Author List / Publisher List


  • Retail Price: ₹ 10628/- [ 11.00% off ]

    Seller Price: ₹ 9459

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Frank Breitling, Stefan D?bel
    PublisherJohn Wiley
    ISBN9780471178477
    Pages162
    BindingPaperback
    LanguageEnglish
    Publish YearOctober 1999

    Description

    John Wiley Recombinant Antibodies Edition 1999 by Frank Breitling, Stefan D?bel

    As new recombinant DNA technology continues to join with cellular and molecular immunology, the field of antibody engineering has become a flourishing discipline. Antibody genes are now being cloned, genetically manipulated, and expressed to produce antigen binding proteins. Recombinant Antibodies addresses this burgeoning field with its comprehensive survey of the developing possibilities for producing specific antibodies by combinatorial methods. Following a comprehensive introduction to the field, the book is divided into four parts: a detailed introduction to the underlying concepts of recombinant antibodies, a description of the various methods for the generation of recombinant antibodies, their production and purification, and various designs and applications of genetically engineered proteins. The combination of these techniques substantially extends the functionality of natural antibodies. In addition, the book will focus on: Hybridoma immortalization. Generation and functional screening of highly complex antibody gene libraries. Human monoclonal antibodies to highly toxic and pathogenic antigens. Improving specificity or affinity of antibodies.New agents for cancer diagnosis and therapy. Genetic fusions for the production of bi- and multifunctional molecules. Production of large quantities of recombinant antibodies. New methods of purification. Emerging technologies. Recombinant Antibodies is the first general overview of the emerging field of antibody engineering and will serve as the definitive source for researchers and engineers in biology and medicine, biochemistry, immunology, and molecular biology, as well as anyone who is interested in biotechnology and antibody engineering.